XML 75 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive (loss) income
Retained earnings
Beginning balance (in shares) at Jan. 02, 2021   43,780,075      
Beginning balance at Jan. 02, 2021 $ 938,033 $ 438 $ 17,752 $ (32,760) $ 952,603
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   178,803      
Exercise of stock options 10,995 $ 1 10,994 0 0
Withholdings from vesting of restricted stock (in shares)   (41,523)      
Withholdings from vesting of restricted stock  (4,019) $ 0 (4,019) 0 0
Restricted stock activity (in shares)   199,134      
Restricted stock activity 0 $ 2 (2) 0 0
Stock-based compensation expense 21,029 $ 0 21,029 0 0
Repurchase of common stock (in shares)   (2,967,619)      
Repurchases of common stock (299,339) $ (30) (45,754) 0 (253,555)
Cash dividends declared and paid (60,124) 0 0 0 (60,124)
Comprehensive income 343,611 $ 0 0 3,863  
Net income (loss) 339,748       339,748
Ending balance (in shares) at Jan. 01, 2022   41,148,870      
Ending balance at Jan. 01, 2022 950,186 $ 411 0 (28,897) 978,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   76,550      
Exercise of stock options 4,457 $ 0 4,457 0 0
Withholdings from vesting of restricted stock (in shares)   (74,307)      
Withholdings from vesting of restricted stock  (6,930) $ 0 (6,930) 0 0
Restricted stock activity (in shares)   288,206      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 21,879 $ 0 21,879 0 0
Repurchase of common stock (in shares)   (3,747,187)      
Repurchases of common stock (299,667) $ (37) (19,403) 0 (280,227)
Cash dividends declared and paid (118,113) 0 0 0 (118,113)
Comprehensive income 244,597 $ 0 0 (5,441)  
Net income (loss) $ 250,038       250,038
Ending balance (in shares) at Dec. 31, 2022 37,692,132 37,692,132      
Ending balance at Dec. 31, 2022 $ 796,409 $ 377 0 (34,338) 830,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 64,700 64,700      
Exercise of stock options $ 4,418 $ 1 4,417 0 0
Withholdings from vesting of restricted stock (in shares)   (64,952)      
Withholdings from vesting of restricted stock  (5,024) $ (1) (4,652) 0 (371)
Restricted stock activity (in shares)   305,610      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 19,463 $ 0 19,463 0 0
Repurchase of common stock (in shares)   (1,446,269)      
Repurchases of common stock (100,034) $ (14) (18,325) 0 (81,695)
Cash dividends declared and paid (112,005) 0 0 0 (112,005)
Comprehensive income 242,923 0 0 10,423  
Net income (loss) 232,500       232,500
Other $ (900) $ 0 (900) 0 0
Ending balance (in shares) at Dec. 30, 2023 36,551,221 36,551,221      
Ending balance at Dec. 30, 2023 $ 845,250 $ 366 $ 0 $ (23,915) $ 868,799